ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,828,937 | -9.2% | 1,838,356 | +42.3% | 0.00% | 0.0% |
| Q2 2023 | $6,419,750 | -36.6% | 1,292,141 | -36.9% | 0.00% | -33.3% |
| Q1 2023 | $10,123,494 | +67241.8% | 2,049,256 | -14.3% | 0.00% | -25.0% |
| Q4 2022 | $15,033 | -99.9% | 2,390,104 | +37.8% | 0.00% | -42.9% |
| Q3 2022 | $18,732,000 | +30.9% | 1,734,787 | +38.3% | 0.01% | +40.0% |
| Q2 2022 | $14,306,000 | +94.8% | 1,254,688 | +55.7% | 0.01% | +150.0% |
| Q1 2022 | $7,344,000 | -33.9% | 805,987 | +8.2% | 0.00% | -33.3% |
| Q4 2021 | $11,114,000 | +26.8% | 744,728 | +118.3% | 0.00% | 0.0% |
| Q3 2021 | $8,768,000 | +1438.2% | 341,155 | +1461.8% | 0.00% | – |
| Q2 2021 | $570,000 | -26.1% | 21,844 | 0.0% | 0.00% | – |
| Q1 2021 | $771,000 | -32.7% | 21,844 | -51.8% | 0.00% | – |
| Q4 2020 | $1,145,000 | -37.5% | 45,353 | -6.6% | 0.00% | -100.0% |
| Q3 2020 | $1,831,000 | +283.9% | 48,548 | +164.2% | 0.00% | – |
| Q4 2019 | $477,000 | -7.6% | 18,373 | -3.0% | 0.00% | – |
| Q3 2019 | $516,000 | – | 18,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |